{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:58:24Z","timestamp":1780405104598,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme disorder in the world. Its main function is to generate NADPH that is required for anti-oxidative pathway in the cells especially in red blood cells (RBC). G6PD deficiency is X-linked and thus subject to random X-chromosome inactivation in women giving them mosaic expression of G6PD activities in their individual cells. This phenomenon makes it difficult for diagnosis with the currently available G6PD qualitative diagnostic tests. With the rolling out of newly marketed anti-malarial drug tafenoquine, which has a long half-life, screening for G6PD deficiency becomes a necessity where those with\u2009&lt;\u200970% G6PD activity cannot receive this drug. Thus, evidence for a quantitative cut-off for G6PD activity is needed to ensure safe drug administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RBC models were developed to analyse the effect of oxidant on RBC oxidative markers namely total glutathione (GSH)and malondialdehyde (MDA). G6PD activity was measured using quantitative assay from Trinity Biotech and was correlated with cytofluorometric assay. RBC from two\u00a0G6PD heterozygous women with different G6PD activities were also analysed for comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There was a negative correlation between G6PD activity and CuCl concentration and a strong association between G6PD activities and proportion of G6PD normal RBC in CuCl-treated models and in ex vivo RBC. However, in terms of oxidative stress markers analyses, unlike the hypothesis where the lower G6PD activity, the higher MDA and the lower GSH level, the CuCl RBC model showed that in low G6PD activities (10\u201330%) cells, the MDA level is lower compared to the rest of the models (p\u2009&lt;\u20090.05). The ex vivo models however were in line with the hypothesis, although the result was not significant (p\u2009=\u20090.5). There was a significant difference between RBC with\u2009&lt;\u200960% and those with\u2009&gt;\u200980% G6PD activities in CuCl RBC model, but not in ex vivo RBC (p\u2009=\u20090.5). Genotyping heterozygous subjects showed G6PDViangchan variant with 2.97 U\/gHb (33% activity) and 6.58 U\/gHb (74% activity).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The GSH analysis has pointed to the 60% G6PD activity cut-off and this data is supportive of the old World Health Organization threshold for intermediate upper limit of 60% G6PD activity. However, there are significant limitations in using MDA assay with CuCl RBC model because the RBC was already stressed due to the copper treatment and thus present a different result when compared to the ex vivo model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03272-y","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T08:02:58Z","timestamp":1592380978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determining a critical threshold for G6PD activity below which red blood cell response to oxidative stress is poor"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-0498","authenticated-orcid":false,"given":"Maria","family":"Swastika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida R.","family":"Harahap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia V.","family":"Panggalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Widia A.","family":"Jusman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari W.","family":"Satyagraha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"3272_CR1","first-page":"1303","volume":"91","author":"L Luzzatto","year":"2006","unstructured":"Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica. 2006;91:1303\u20136.","journal-title":"Haematologica"},{"key":"3272_CR2","first-page":"1277","volume":"72","author":"JE Frank","year":"2005","unstructured":"Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72:1277\u201382.","journal-title":"Am Fam Physician"},{"key":"3272_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0140-6736(61)92120-1","volume":"277","author":"S Ohno","year":"1961","unstructured":"Ohno S, Makino S. The single-X nature of sex chromatin in man. Lancet. 1961;277:78\u20139.","journal-title":"Lancet"},{"key":"3272_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1073\/pnas.48.1.9","volume":"48","author":"E Beutler","year":"1962","unstructured":"Beutler E, Yeh M, Fairbanks VF. The normal human female as a mosaic of X-chromosome activity: studies using the gene for G-6-PD-deficiency as a marker. Proc Natl Acad Sci USA. 1962;48:9\u201316.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3272_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/MMBR.62.2.362-378.1998","volume":"62","author":"T Goto","year":"1998","unstructured":"Goto T, Monk M. Regulation of X-chromosome inactivation in development in mice and humans. Microbiol Mol Biol Rev. 1998;62:362\u201378.","journal-title":"Microbiol Mol Biol Rev"},{"key":"3272_CR6","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.1128\/MCB.00810-06","volume":"26","author":"F Savarese","year":"2006","unstructured":"Savarese F, Flahndorfer K, Jaenisch R, Busslinger M, Wutz A. Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation. Mol Cell Biol. 2006;26:7167\u201377.","journal-title":"Mol Cell Biol"},{"key":"3272_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trsl.2014.09.009","volume":"165","author":"JK Baird","year":"2015","unstructured":"Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res. 2015;165:677\u201388.","journal-title":"Transl Res."},{"key":"3272_CR8","doi-asserted-by":"publisher","first-page":"e0004457","DOI":"10.1371\/journal.pntd.0004457","volume":"10","author":"AW Satyagraha","year":"2016","unstructured":"Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, et al. Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia. PLoS Negl Trop Dis. 2016;10:e0004457.","journal-title":"PLoS Negl Trop Dis."},{"key":"3272_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/cid\/ciy319","volume":"67","author":"CS Chu","year":"2018","unstructured":"Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, et al. Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria. Clin Infect Dis. 2018;67:1543\u20139.","journal-title":"Clin Infect Dis"},{"key":"3272_CR10","unstructured":"CDC. Tafenoquine approved for malaria prophylaxis and treatment. Travelers\u2019 Health. https:\/\/wwwnc.cdc.gov\/travel\/news-announcements\/tafenoquine-malaria-prophylaxis-and-treatment. Accessed 1 Oct 2019."},{"key":"3272_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","volume":"97","author":"R Rueangweerayut","year":"2017","unstructured":"Rueangweerayut R, Bancone G, Harrell EJ, Beelen AP, Kongpatanakul S, M\u00f6hrle JJ, et al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol Variant) versus G6PD-normal volunteers. Am J Trop Med Hyg. 2017;97:702\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"3272_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.4269\/ajtmh.14-0194","volume":"91","author":"N LaRue","year":"2014","unstructured":"LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S, et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg. 2014;91:854\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"3272_CR13","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/anie.198610581","volume":"25","author":"H Sies","year":"1986","unstructured":"Sies H. Biochemistry of oxidative stress. Angew Chem Int Ed Engl. 1986;25:1058\u201371.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3272_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-4649-8_1","volume-title":"Oxidative stress and vascular disease","author":"H Sies","year":"2000","unstructured":"Sies H. What is oxidative stress? In: Keaney JF, editor. Oxidative stress and vascular disease. Boston: Springer; 2000. p. 1\u20138. https:\/\/doi.org\/10.1007\/978-1-4615-4649-8_1."},{"key":"3272_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10408360903142326","volume":"46","author":"D Giustarini","year":"2009","unstructured":"Giustarini D, Dalle-Donne I, Tsikas D, Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci. 2009;46:241\u201381.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3272_CR16","first-page":"271","volume":"45","author":"T Yoshikawa","year":"2002","unstructured":"Yoshikawa T, Naito Y. What is oxidative stress. JMAJ. 2002;45:271\u20136.","journal-title":"JMAJ."},{"key":"3272_CR17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1590\/S0100-879X2005000700003","volume":"38","author":"JG Scandalios","year":"2005","unstructured":"Scandalios JG. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res. 2005;38:995\u20131014.","journal-title":"Braz J Med Biol Res"},{"key":"3272_CR18","first-page":"13","volume":"23","author":"MA Srour","year":"2000","unstructured":"Srour MA, Bilto YY, Juma M, Irhimeh MR. Exposure of human erythrocytes to oxygen radicals causes loss of deformability, increased osmotic fragility, lipid peroxidation and protein degradation. Clin Hemorheol Microcirc. 2000;23:13\u201321.","journal-title":"Clin Hemorheol Microcirc."},{"key":"3272_CR19","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1172\/JCI112196","volume":"76","author":"LM Snyder","year":"1985","unstructured":"Snyder LM, Fortier NL, Trainor J, Jacobs J, Leb L, Lubin B, et al. Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking. J Clin Invest. 1985;76:1971\u20137.","journal-title":"J Clin Invest."},{"key":"3272_CR20","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1089\/ars.2012.4867","volume":"18","author":"JM Rifkind","year":"2013","unstructured":"Rifkind JM, Nagababu E. Hemoglobin redox reactions and red blood cell aging. Antioxid Redox Signal. 2013;18:2274\u201383.","journal-title":"Antioxid Redox Signal"},{"key":"3272_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1172\/JCI106833","volume":"51","author":"M Boulard","year":"1972","unstructured":"Boulard M, Blume K-G, Beutler E. The effect of copper on red cell enzyme activities. J Clin Invest. 1972;51:459\u201361.","journal-title":"J Clin Invest."},{"key":"3272_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/10715768809066894","volume":"4","author":"A Fernandes","year":"1988","unstructured":"Fernandes A, Mira ML, Azevedo MS, Manso C. Mechanisms of hemolysis induced by copper. Free Radic Res Commun. 1988;4:291\u20138.","journal-title":"Free Radic Res Commun."},{"key":"3272_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265\u201375.","journal-title":"J Biol Chem"},{"key":"3272_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/srep00299","volume":"2","author":"SS Shah","year":"2012","unstructured":"Shah SS, Diakite SAS, Traore K, Diakite M, Kwiatkowski DP, Rockett KA, et al. A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep. 2012;2:299.","journal-title":"Sci Rep"},{"key":"3272_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(SICI)1096-8652(199601)51:1<19::AID-AJH4>3.0.CO;2-A","volume":"51","author":"C-S Huang","year":"1996","unstructured":"Huang C-S, Hung K-L, Huang M-J, Li Y-C, Liu T-H, Tang TK. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am J Hematol. 1996;51:19\u201325.","journal-title":"Am J Hematol"},{"key":"3272_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/humu.9010","volume":"19","author":"I Nuchprayoon","year":"2002","unstructured":"Nuchprayoon I, Sanpavat S, Nuchprayoon S. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: g6PD Viangchan (871G\u2009>\u2009A) is the most common deficiency variant in the Thai population. Hum Mutat. 2002;19:185\u2013185.","journal-title":"Hum Mutat"},{"key":"3272_CR27","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1016\/0006-2952(82)90136-8","volume":"31","author":"JMC Gutteridge","year":"1982","unstructured":"Gutteridge JMC, Halliwell B. The role of superoxide and hydroxyl radicals in the degradation of DNA and deoxyribose induced by a copper phenanthroline complex. Biochem Pharmacol. 1982;31:2801\u20135.","journal-title":"Biochem Pharmacol"},{"key":"3272_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1006\/abbi.1996.9788","volume":"337","author":"JO Ossola","year":"1997","unstructured":"Ossola JO, Groppa MD, Tomaro ML. Relationship between oxidative stress and heme oxygenase induction by copper sulfate. Arch Biochem Biophys. 1997;337:332\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"3272_CR29","doi-asserted-by":"publisher","first-page":"1447S","DOI":"10.1093\/jn\/130.5.1447S","volume":"130","author":"SR Powell","year":"2000","unstructured":"Powell SR. The Antioxidant properties of zinc. J Nutr. 2000;130:1447S\u201354S.","journal-title":"J Nutr"},{"key":"3272_CR30","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/BF01954948","volume":"38","author":"S Ribarov","year":"1982","unstructured":"Ribarov S, Benov L, Benchev I, Monovich O, Markova V. Hemolysis and peroxidation in heavy metal-treated erythrocytes; GSH content and activities of some protecting enzymes. Experientia. 1982;38:1354\u20135.","journal-title":"Experientia"},{"key":"3272_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0006-2952(02)01172-3","volume":"64","author":"DA Dickinson","year":"2002","unstructured":"Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol. 2002;64:1019\u201326.","journal-title":"Biochem Pharmacol"},{"key":"3272_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fphar.2014.00196","volume":"5","author":"K Aquilano","year":"2014","unstructured":"Aquilano K, Baldelli S, Ciriolo MR. Glutathione: new roles in redox signaling for an old antioxidant. Front Pharmacol. 2014;5:196.","journal-title":"Front Pharmacol."},{"key":"3272_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF02783258","volume":"4","author":"GW Rafter","year":"1982","unstructured":"Rafter GW. The effect of copper on glutathione metabolism in human leukocytes. Biol Trace Elem Res. 1982;4:191\u20137.","journal-title":"Biol Trace Elem Res"},{"key":"3272_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/10426509408016396","volume":"90","author":"RC Smith","year":"1994","unstructured":"Smith RC, Reed VD, Hill WE. Oxidation of thiols by copper(II). Phosphorus Sulfur Silicon Relat Elem. 1994;90:147\u201354.","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"3272_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/10715769900300571","volume":"31","author":"AV Kachur","year":"1999","unstructured":"Kachur AV, Koch CJ, Biaglow JE. Mechanism of copper-catalyzed autoxidation of cysteine. Free Radic Res. 1999;31:23\u201334.","journal-title":"Free Radic Res."},{"key":"3272_CR36","first-page":"1211","volume":"17","author":"HG Osman","year":"2013","unstructured":"Osman HG, Zahran FM, El-Sokkary AMA, Sabry AM. Oxidative stress and antioxidant defense in Egyptian favism patients. Eur Rev Med Pharmacol Sci. 2013;17:1211\u20137.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"3272_CR37","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1089\/ars.2014.6142","volume":"22","author":"H Tang","year":"2015","unstructured":"Tang H, Ho H, Wu P, Chen S, Kuypers FA, Cheng M, et al. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal. 2015;22:744\u201359.","journal-title":"Antioxid Redox Signal"},{"key":"3272_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12887-017-0920-y","volume":"17","author":"Z Gong","year":"2017","unstructured":"Gong Z, Tian G, Huang Q, Wang Y, Xu H. Reduced glutathione and glutathione disulfide in the blood of glucose-6-phosphate dehydrogenase-deficient newborns. BMC Pediatr. 2017;17:172.","journal-title":"BMC Pediatr."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03272-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03272-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T19:09:30Z","timestamp":1623870570000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03272-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3272"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03272-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.19598\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19598\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19598\/v2","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance for the study was approved by The Ethics Committee of The Faculty of Medicine, Universitas Indonesia (No. 640\/UN2.F1\/ETIK\/2016). Informed consent was obtained from all study subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for this publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}